FPN || Conferences

Few psoriatic arthritis patients achieve minimal disease activity on methotrexate

Posted on: 05/12/2014 - 16:16

BOSTON – It’s time to test whether methotrexate is really up to snuff as a first-line therapy for psoriatic arthritis, Canadian investigators say. They base that recommendation on findings from a...

Field of Interest: Rheumatology

Type: News Item

Recommendations mixed on oral contraceptives for female migraineurs

Posted on: 04/12/2014 - 16:22

SCOTTSDALE, ARIZ. – Experts have not reached consensus on prescribing oral contraceptives for women with migraine, revealing the need for better studies of stroke risk in these patients, said Dr....

Field of Interest: Pulmonology

Type: News Item

Randomized trial assesses behavioral weight loss as migraine treatment

Posted on: 03/12/2014 - 22:33

SCOTTSDALE, ARIZ. - The first randomized, controlled trial of behavioral weight loss as a treatment for migraine in women is underway, with results expected in mid-2016. The trial “provides an...

Field of Interest: Pulmonology

Type: News Item

Psoriasis is independently associated with advanced liver fibrosis

Posted on: 03/12/2014 - 19:16

AMSTERDAM – Older psoriasis patients have an increased risk of advanced hepatic fibrosis even if they have mild skin disease that has never required systemic therapy. This finding from the...

Field of Interest: Dermatology

Type: News Item

Psoriasis is independently associated with advanced liver fibrosis

Posted on: 03/12/2014 - 19:16

AMSTERDAM – Older psoriasis patients have an increased risk of advanced hepatic fibrosis even if they have mild skin disease that has never required systemic therapy. This finding from the...

Field of Interest: Gastroentero...

Type: News Item

Tapering TNFi’s safe and much cheaper in RA

Posted on: 01/12/2014 - 21:47

BOSTON – Tapering but perhaps not completely stopping tumor necrosis factor inhibitors can result in good control of rheumatoid arthritis with considerable cost savings, according to investigators in...

Field of Interest: Rheumatology

Type: News Item

Nonsteroidal ‘DAGR’ looks sharp against RA

Posted on: 26/11/2014 - 16:06

BOSTON – A nonsteroidal investigational drug that acts on the glucocorticoid receptor was superior to placebo and noninferior to higher-dose prednisone in adults with rheumatoid arthritis,...

Field of Interest: Rheumatology

Type: News Item

Golimumab effective against nonradiographic axial spondyloarthritis with inflammation

Posted on: 26/11/2014 - 15:16

BOSTON – Golimumab was significantly better than placebo at reducing disease activity and inflammation in patients with nonradiographic axial spondyloarthritis, but only among those who were positive...

Field of Interest: Rheumatology

Type: News Item

VIDEO: DAGR may prove to be safer alternative to glucocorticoids

Posted on: 24/11/2014 - 22:19

BOSTON– In the search for safer alternatives to glucocorticoid therapy, DAGR (PF-0417327) may prove to be a contender. The investigational drug is a selective, high-affinity, dissociated agonist of...

Field of Interest: Rheumatology

Type: News Item

Simple risk score predicts dementia risk in type 2 diabetes

Posted on: 24/11/2014 - 20:44

BERLIN – The first-ever dementia risk score designed specifically for patients with type 2 diabetes has successfully undergone external validation and is ready for everyday use by clinicians, Rachel...

Field of Interest: Geriatrics

Type: News Item

« first
‹ previous
…
16
17
18
19
20
21
22
23
24
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters